Literature DB >> 20056942

Introduction to cardiotoxicity review series.

Thomas Force1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20056942     DOI： 10.1161/CIRCRESAHA.109.210724

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  3 in total

Review 1.  Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval).

Authors:  Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

2.  Global Longitudinal Strain Accuracy for Cardiotoxicity Prediction in a Cohort of Breast Cancer Patients During Anthracycline and/or Trastuzumab Treatment.

Authors:  Eliza de Almeida Gripp; Gabriela Escudini de Oliveira; Luiz Augusto Feijó; Marcelo Iorio Garcia; Sergio Salles Xavier; Andréa Silvestre de Sousa
Journal:  Arq Bras Cardiol       Date:  2018-02       Impact factor: 2.000

Review 3.  Dexrazoxane for the treatment of chemotherapy-related side effects.

Authors:  Seppo W Langer
Journal:  Cancer Manag Res       Date:  2014-09-15       Impact factor: 3.989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.